A02217 Summary:

BILL NOA02217
 
SAME ASNo Same As
 
SPONSORSantabarbara
 
COSPNSRD'Urso, Simon, Sayegh, Fall, Gottfried, Ortiz, Griffin, Dickens, Pichardo, Abbate, Hevesi, Miller MG, Gunther, Arroyo, McMahon, Hyndman, Ramos, Blake, Ashby, McDonough, Morinello, Miller B, Smullen, Steck, Miller ML
 
MLTSPNSRDenDekker, DeStefano, Galef, Thiele
 
Amd §3360, Pub Health L
 
Relates to allowing for the use of medical marihuana for autism spectrum disorder.
Go to top    

A02217 Actions:

BILL NOA02217
 
01/22/2019referred to health
01/08/2020referred to health
Go to top

A02217 Committee Votes:

Go to top

A02217 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A02217 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2217
 
                               2019-2020 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 22, 2019
                                       ___________
 
        Introduced  by  M.  of  A. SANTABARBARA -- read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law, in relation to allowing  for  the
          use of medical marihuana for autism spectrum disorder
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph (a) of subdivision  7  of  section  3360  of  the
     2  public  health  law,  as  amended by chapter 273 of the laws of 2018, is
     3  amended to read as follows:
     4    (a) "Serious condition" means:
     5    (i) having one of the following severe debilitating or  life-threaten-
     6  ing conditions: cancer, positive status for human immunodeficiency virus
     7  or  acquired  immune deficiency syndrome, amyotrophic lateral sclerosis,
     8  Parkinson's disease, multiple sclerosis, damage to the nervous tissue of
     9  the spinal cord with objective neurological  indication  of  intractable
    10  spasticity,   epilepsy,   inflammatory   bowel   disease,  neuropathies,
    11  Huntington's disease, autism spectrum  disorder,  post-traumatic  stress
    12  disorder,  pain that degrades health and functional capability where the
    13  use of medical marihuana is an alternative to opioid use, substance  use
    14  disorder, or as added by the commissioner; and
    15    (ii) any of the following conditions where it is clinically associated
    16  with,  or  a  complication  of,  a condition under this paragraph or its
    17  treatment: cachexia or wasting syndrome; severe or chronic pain;  severe
    18  nausea; seizures; severe or persistent muscle spasms; or such conditions
    19  as are added by the commissioner.
    20    §  2.  This act shall take effect immediately; provided, however, that
    21  the amendments to section 3360 of the public health law, made by section
    22  one of this act, shall not affect the repeal of such section  and  shall
    23  be deemed repealed therewith.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD03354-01-9
Go to top